{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:02:27Z","timestamp":1791093747611,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.critrevonc.2009.10.003","type":"journal-article","created":{"date-parts":[[2009,11,8]],"date-time":"2009-11-08T09:15:34Z","timestamp":1257671734000},"page":"27-42","source":"Crossref","is-referenced-by-count":76,"title":["Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review"],"prefix":"10.1016","volume":"75","author":[{"given":"George","family":"Pentheroudakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2009.10.003_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.seminoncol.2008.10.006","article-title":"Treatment for patients with unknown primary cancer and favourable prognostic factors","volume":"36","author":"Hainsworth","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib2","first-page":"474","article-title":"Multifocal extraovarian serous carcinoma: a histochemical and immunohistochemical study","volume":"9","author":"Resta","year":"1988","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarin peritoneal serous papillary carcinoma: a case\u2013control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00004347-198909000-00001","article-title":"Serous papillary carcinomas arising from the peritoneum and ovaries","volume":"8","author":"Wick","year":"1989","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.1999.5711","article-title":"Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum","volume":"76","author":"Schorge","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004347-200010000-00010","article-title":"Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum","volume":"19","author":"Terai","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00004347-199704000-00012","article-title":"Role of p53 alteration in primary peritoneal carcinoma","volume":"16","author":"Moll","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.2001.6176","article-title":"Allelotype of papillary serous peritoneal carcinomas","volume":"82","author":"Cass","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO;2-T","article-title":"A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma","volume":"79","author":"Kowalski","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004347-200110000-00005","article-title":"Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma","volume":"20","author":"Halperin","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1525-1438.2003.13605.x","article-title":"Molecular similarities between primary peritoneal and primary ovarian carcinomas","volume":"13","author":"Chen","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/P51M-B66M-JFKW-ER5A","article-title":"Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum","volume":"114","author":"Huang","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0046-8177(00)80252-X","article-title":"Identification of a novel 9cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum","volume":"31","author":"Huang","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0046-8177(99)90277-0","article-title":"Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma","volume":"30","author":"Quezado","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0029-7844(98)00223-3","article-title":"BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum","volume":"92","author":"Bandera","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jnci\/90.11.841","article-title":"Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations","volume":"90","author":"Schorge","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","article-title":"Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma\u2014a Gynecologic Oncology Group Study","volume":"89","author":"Bloss","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-8258(88)80010-6","article-title":"Peritoneal papillary carcinoma","volume":"31","author":"Lele","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000478-198811000-00003","article-title":"Serous surface papillary carcinoma. A clinicopathologic study of ten cases and comparison with stage III\/IV ovarian serous carcinoma","volume":"12","author":"Mills","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7326\/0003-4819-111-3-213","article-title":"Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma","volume":"111","author":"Strnad","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5","article-title":"Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases","volume":"64","author":"Dalrymple","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib22","first-page":"89","article-title":"Papillary serous carcinoma of the peritoneum","volume":"75","author":"Fromm","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/1097-0142(19900915)66:6<1091::AID-CNCR2820660602>3.0.CO;2-F","article-title":"Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy","volume":"66","author":"Ransom","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0046-8177(90)90081-F","article-title":"Serous surface carcinoma of the peritoneum: a clincopathologic study of 22 cases","volume":"21","author":"Truong","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1993.1267","article-title":"Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma","volume":"51","author":"Killackey","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1525-1438.1994.04010043.x","article-title":"Peritoneal adenocarcinoma serous of Mullerian type: a subgroup of women presenting with peritoneal carcinomatosis","volume":"4","author":"Fowler","year":"1994","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1097-0142(19950801)76:3<429::AID-CNCR2820760313>3.0.CO;2-8","article-title":"Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study","volume":"76","author":"Zhou","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1996.0060","article-title":"Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma","volume":"60","author":"Baruch","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib29","first-page":"79","article-title":"Ovarian surface serous papillary carcinomas: a clinicopathologic study","volume":"17","author":"Liapis","year":"1996","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib30","first-page":"171","article-title":"Primary serous papillary carcinoma of the peritoneum: a report of 18 patients","volume":"18","author":"Taus","year":"1997","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/gyno.1997.4843","article-title":"Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin","volume":"67","author":"Piver","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9098(199807)68:3<173::AID-JSO8>3.0.CO;2-2","article-title":"Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III\u2013IV ovarian papillary serous carcinoma","volume":"68","author":"Piura","year":"1998","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/gyno.1998.5159","article-title":"Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum","volume":"71","author":"Kennedy","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jso.10166","article-title":"Lymphatic spread among women with primary peritoneal carcinoma","volume":"81","author":"Eltabbakh","year":"2002","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/02841860510029554","article-title":"Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?","volume":"44","author":"Pentheroudakis","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ygyno.2007.02.020","article-title":"Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma","volume":"105","author":"Choi","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1631\/jzus.B0820051","article-title":"Advanced primary peritoneal carcinoma: clinicopathologic and prognostic factor analyses","volume":"9","author":"Zhang","year":"2008","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib38","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajog.2004.02.067","article-title":"Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause","volume":"191","author":"Piek","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cursur.2005.03.001","article-title":"Cytoreductive surgery in the management of malignant ascites form adenocarcinoma of unknown primary","volume":"62","author":"Spurgeon","year":"2005","journal-title":"Curr Surg"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2008.11.030","article-title":"Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status and angiogenic marker expression: a GOG study","volume":"112","author":"Rubatt","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib43","first-page":"19126650","article-title":"Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes","author":"Sasaki","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2008.11.031","article-title":"Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers","volume":"112","author":"Lee","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2008.08.020","article-title":"Associations between p53 overexpression and multiple measures of clinical outcome in high-risk early stage or suboptimally-resected advanced stage epithelial ovarian cancers. A GOG study","volume":"111","author":"Darcy","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib46","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/PAS.0b013e31816fd555","article-title":"Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data","volume":"32","author":"Vang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib48","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1371\/journal.pone.0001138","article-title":"HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients","volume":"2","author":"Tuefferd","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib49","first-page":"195","article-title":"Protein levels and gene expressions of the epidermal growth factor receptors HER1, HER2, HER3 and HER4 in benign and malignant epithelial ovarian tumours","volume":"33","author":"Steffensen","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib50","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jjco\/hyd092","article-title":"BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma","volume":"30","author":"Wang","year":"2000","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.1993.1240","article-title":"Advanced ovarian carcinoma: molecular evidence of unifocal origin","volume":"51","author":"Li","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib53","first-page":"1361","article-title":"BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis","volume":"60","author":"Schorge","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib54","first-page":"19195765","article-title":"GCIG proposals for changes of the current FIGO staging system","author":"Petru","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2007.10.001","article-title":"The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIc epithelial ovarian, fallopian tube and primary peritoneal cancer","volume":"108","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib56","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0959-8049(03)00547-1","article-title":"Diagnostic and therapeutic management of cancer of unknown primary","volume":"39","author":"Pavlidis","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib57","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.ejca.2007.06.023","article-title":"Switching benchmarks in cancer of unknown primary: from autopsy to microarray","volume":"43","author":"Pentheroudakis","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ctrv.2006.08.004","article-title":"Perspectives for targeted therapies in cancer of unknown primary site","volume":"32","author":"Pentheroudakis","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.critrevonc.2009.10.003_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminoncol.2008.10.005","article-title":"Treatment for patients with unknown primary carcinoma and unfavourable prognostic factors","volume":"36","author":"Greco","year":"2009","journal-title":"Semin Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T13:29:41Z","timestamp":1544880581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842809002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1040842809002017"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2009.10.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}